Certara opened at $11.73, in line with its previous close of $11.73. In the last trading session, the stock traded between $11.29 and $11.97. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Certara is now worth
$ 30.24
Resulting in a loss of
$ 69.76 (69.76%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 8 Analysts
Buy
37.5%
Hold
62.5%
Sell
0%
Markets Today
Today's Change
+$0.18 (+1.51%)
Day High
$11.97
Day Low
$11.29
Day Open
$11.73
Prev Close
$11.73
Volume
27,25,094
1W Return
7.41%
1M Return
28.82%
3M Return
46.55%
6M Return
132.11%
1Y Return
38.78%
Fundamentals
Market Cap ($ Mn)
1,816
PE Ratio
-
PB Ratio
1.32
PEG Ratio
-
ROE
-0.15%
ROCE
1.93%
EPS (TTM)
$0.04
Investment Returns
1 Week
7.41%
1 Month
28.82%
3 Months
46.55%
6 Months
132.11%
9 Months
71.82%
Financials
Quarterly
All values in $ Mn
104.6
Jun 25
104.6
Sep 25
103.6
Dec 25
106.9
Mar 26
93.3
Jun 26
94.9
Sep 26
Updates
6Nov
Barclays raises Certara price target to $12, maintains Equal-Weight
Barclays raised Certara's price target from $9 to $12. The firm maintained an Equal-Weight rating on the stock. Analyst Luke Sergott issued the revised price target.
6 days ago
16Oct
Keybanc maintains overweight on Certara, lifts price target to $12
Keybanc maintains Overweight rating on Certara. Price target raised from $9 to $12. Analyst Scott Schoenhaus issued the update.
27 days ago
30Sep
UBS downgrades Certara to Neutral, keeps $10 price target
UBS analyst Kevin Caliendo downgraded Certara from Buy to Neutral. Price target for Certara remains unchanged at $10 per share. The downgrade reflects a revised outlook without a change in valuation estimate.
Certara's Q2 results showed adjusted EPS of $0.08, missing the $0.09 estimate by 11.11%, while remaining flat year-over-year. Sales grew 0.99% YoY to $93.271 million but missed the $98.392 million consensus by 5.20%. The data indicates margin pressure as revenue growth failed to drive proportional earnings gains.
3mo ago
16Jul
Certara to report Q2 2026 financial results on August 4
Certara, Inc. announced it will report its Q2 2026 financial results before market open on August 4, 2026, followed by a conference call at 8:30AM ET. Investors must register online in advance to join the call, with a webcast available on the company's investor relations website. The company specializes in model-informed drug development, serving over 2,600 clients globally.
4mo ago
15Jul
Pomerantz investigates Certara after weak Q1 results and CFO exit
Pomerantz LLP is investigating Certara regarding potential securities fraud after weak Q1 2026 results and the resignation of CFO John Gallagher. Services revenue declined 4% year-over-year to $57.2 million, leading to a 19% stock drop on May 11, 2026. The CFO's resignation announcement on June 17, 2026, caused a further 8.13% decline in stock price.
